| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Surgical Oncology [K. K. H., M. W-H., M-C. H.], Tumor Biology [J. D., T-J. L., M-C. H.], Thoracic and Cardiovascular Surgery [S. G. S.], and Head and Neck Surgery [T-J. L., G. C.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Apoptosis is a mode of cell death that is carefully regulated based on cellular and environmental signals. The ability to modulate the individual cellular machinery and thereby to promote apoptosis is an important strategy in cancer therapy. It has previously been shown that overexpression of the transcription factor E2F-1 can induce apoptosis in quiescent rat embryo fibroblasts. This effect has been reported to occur in a p53-dependent manner. To investigate whether overexpression of E2F-1 could also induce apoptosis in human cancer cells, a recombinant adenovirus vector containing the transgene E2F-1 under control of the cytomegalovirus promoter (Ad5CMVE2F) was used to induce high levels of the E2F-1 protein in human breast and ovarian carcinoma cell lines. Significant morphological changes occurred in four of the five cell lines within 48 h of transduction with the Ad5CMVE2F. These changes were consistent with apoptosis, which was confirmed further by DNA fragmentation assay and fluorescence-activated cell sorting analysis. On the basis of these assays, which show that apoptosis occurred in those cell lines with mutations in the p53 gene, we suggest that the induction of E2F-1-mediated apoptosis does not require wild-type p53 when E2F-1 is overexpressed using an adenovirus-based strategy.
1 This work was supported by the M. D. Anderson Cancer Center Breast Cancer Research Program and Army Breast Cancer Grant DAMD 17-94-J4315 (to M-C. H.), M. D. Anderson Cancer Center Core Grant CA 16672, and NIH Training of Academic Surgical Oncologists Grant CA 09599.
2 To whom requests for reprints should be addressed, at Breast Cancer Basic Science Research Program, Department of Tumor Biology, The University of Texas M. D. Anderson Cancer Center, Box 79, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: (713) 792-3668; Fax: (713) 794-4784.
Received 6/26/97. Accepted 9/22/97.
This article has been cited by other articles:
![]() |
C.-C. Wen, S.-A. Cheng, S.-P. Hsuen, Y.-L. Huang, Z.-K. Kuo, H.-F. Lee, C.-H. Kuo, J.-L. Du, and W.-B. Wang SV40 T/t-Common Polypeptide Specifically Induces Apoptosis in Human Cancer Cells that Overexpress HER2/neu Cancer Res., June 1, 2006; 66(11): 5847 - 5857. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Vorburger, N. Hetrakul, W. Xia, M. Wilson-Heiner, N. Mirza, R. E. Pollock, B. Feig, S. G. Swisher, and K. K. Hunt Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo Mol. Cancer Ther., November 1, 2005; 4(11): 1710 - 1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wang, C. J. Li, P. V. Reddy, and A. B. Pardee Cancer Chemotherapy by Deoxynucleotide Depletion and E2F-1 Elevation Cancer Res., September 1, 2005; 65(17): 7809 - 7814. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Scheijen, M. Bronk, T. van der Meer, D. De Jong, and R. Bernards High Incidence of Thymic Epithelial Tumors in E2F2 Transgenic Mice J. Biol. Chem., March 12, 2004; 279(11): 10476 - 10483. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jiang, C. B. Matranga, D. Cai, V. M. Latham Jr., X. Zhang, A. M. Lowell, F. Martelli, and G. I. Shapiro Flavopiridol-Induced Apoptosis during S Phase Requires E2F-1 and Inhibition of Cyclin A-Dependent Kinase Activity Cancer Res., November 1, 2003; 63(21): 7410 - 7422. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stanelle, T. Stiewe, F. Rodicker, K. Kohler, C. Theseling, and B. M. Putzer Mechanism of E2F1-induced apoptosis in primary vascular smooth muscle cells Cardiovasc Res, August 1, 2003; 59(2): 512 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Vorburger, A. Pataer, K. Yoshida, Y. Liu, X. Lu, S. G. Swisher, and K. K. Hunt The Mitochondrial Apoptosis-Inducing Factor Plays a Role in E2F-1-Induced Apoptosis in Human Colon Cancer Cells Ann. Surg. Oncol., April 1, 2003; 10(3): 314 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chen, C. Capps, J. T. Willerson, and P. Zoldhelyi E2F-1 Regulates Nuclear Factor-{kappa}B Activity and Cell Adhesion: Potential Antiinflammatory Activity of the Transcription Factor E2F-1 Circulation, November 19, 2002; 106(21): 2707 - 2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ding, Y. Wen, B. Spohn, L. Wang, W. Xia, K. Y. Kwong, R. Shao, Z. Li, G. N. Hortobagyi, M.-C. Hung, et al. Proapoptotic and Antitumor Activities of Adenovirus-mediated p202 Gene Transfer Clin. Cancer Res., October 1, 2002; 8(10): 3290 - 3297. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuhn, U. Liebers, C. Gessner, A. Schumacher, C. Witt, J. Schauer, I. Kovesdi, and G. Wolff Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis Eur. Respir. J., September 1, 2002; 20(3): 703 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Farhana, M. Dawson, A. K. Rishi, Y. Zhang, E. Van Buren, C. Trivedi, U. Reichert, G. Fang, M. W. Kirschner, and J. A. Fontana Cyclin B and E2F-1 Expression in Prostate Carcinoma Cells Treated with the Novel Retinoid CD437 Are Regulated by the Ubiquitin-mediated Pathway Cancer Res., July 1, 2002; 62(13): 3842 - 3849. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Russell, J. T. Powers, R. J. Rounbehler, P. M. Rogers, C. J. Conti, and D. G. Johnson ARF Differentially Modulates Apoptosis Induced by E2F1 and Myc Mol. Cell. Biol., March 1, 2002; 22(5): 1360 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. B. Dong, H. L. Yang, M. J. Elliott, and K. M. McMasters Adenovirus-mediated E2F-1 Gene Transfer Sensitizes Melanoma Cells to Apoptosis Induced by Topoisomerase II Inhibitors Cancer Res., March 1, 2002; 62(6): 1776 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Vorburger and K. K. Hunt Adenoviral Gene Therapy Oncologist, February 1, 2002; 7(1): 46 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deng, F. Kloosterbooer, W. Xia, and M.-C. Hung The NH2-Terminal and Conserved Region 2 Domains of Adenovirus E1A Mediate Two Distinct Mechanisms of Tumor Suppression Cancer Res., January 1, 2002; 62(2): 346 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Elliott, Y. B. Dong, H. Yang, and K. M. McMasters E2F-1 Up-Regulates c-Myc and p14ARF and Induces Apoptosis in Colon Cancer Cells Clin. Cancer Res., November 1, 2001; 7(11): 3590 - 3597. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gomez-Manzano, P. Mitlianga, J. Fueyo, H.-Y. Lee, M. Hu, K. B. Spurgers, T. L. Glass, D. Koul, T.-J. Liu, T. J. McDonnell, et al. Transfer of E2F-1 to Human Glioma Cells Results in Transcriptional Up-Regulation of Bcl-2 Cancer Res., September 1, 2001; 61(18): 6693 - 6697. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Shelat, T.-J. Liu, D. L. Hickman-Bick, M. K. Barnhart, T. Vida, P. M. Dillard, J. T. Willerson, and P. Zoldhelyi Growth Suppression of Human Coronary Vascular Smooth Muscle Cells by Gene Transfer of the Transcription Factor E2F-1 Circulation, January 23, 2001; 103(3): 407 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Seewaldt, K. Mrózek, E. C. Dietze, M. Parker, and L. E. Caldwell Human Papillomavirus Type 16 E6 Inactivation of p53 in Normal Human Mammary Epithelial Cells Promotes Tamoxifen-mediated Apoptosis Cancer Res., January 1, 2001; 61(2): 616 - 624. [Abstract] [Full Text] |
||||
![]() |
S. Y. Zhang, S. C. Liu, D. G. Johnson, and A. J. P. Klein-Szanto E2F-1 Gene Transfer Enhances Invasiveness of Human Head and Neck Carcinoma Cell Lines Cancer Res., November 1, 2000; 60(21): 5972 - 5976. [Abstract] [Full Text] |
||||
![]() |
A. Amanullah, B. Hoffman, and D. A. Liebermann Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15INK4B and p16INK4A Blood, July 15, 2000; 96(2): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Zhang, S. C. Liu, L. F. Al-Saleem, D. Holloran, J. Babb, X. Guo, and A. J. P. Klein-Szanto E2F-1: A Proliferative Marker of Breast Neoplasia Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 395 - 401. [Abstract] [Full Text] |
||||
![]() |
K. Hofland, B. O. Petersen, J. Falck, K. Helin, P. B. Jensen, and M. Sehested Differential Cytotoxic Pathways of Topoisomerase I and II Anticancer Agents after Overexpression of the E2F-1/DP-1 Transcription Factor Complex Clin. Cancer Res., April 1, 2000; 6(4): 1488 - 1497. [Abstract] [Full Text] |
||||
![]() |
H. L. Yang, Y. B. Dong, M. J. Elliott, T. J. Liu, and K. M. McMasters Caspase Activation and Changes in Bcl-2 Family Member Protein Expression Associated with E2F-1-mediated Apoptosis in Human Esophageal Cancer Cells Clin. Cancer Res., April 1, 2000; 6(4): 1579 - 1589. [Abstract] [Full Text] |
||||
![]() |
A. Wang, R. Schneider-Broussard, A. P. Kumar, M. C. MacLeod, and D. G. Johnson Regulation of BRCA1 Expression by the Rb-E2F Pathway J. Biol. Chem., February 11, 2000; 275(6): 4532 - 4536. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. G. Shu, C. M. Julin, F. Furman, G. L. Yount, D. Haas-Kogan, and M. A. Israel Overexpression of E2F1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiation Neuro-oncol, January 1, 2000; 2(1): 16 - 21. [Abstract] [PDF] |
||||
![]() |
A. M. Pierce, R. Schneider-Broussard, I. B. Gimenez-Conti, J. L. Russell, C. J. Conti, and D. G. Johnson E2F1 Has Both Oncogenic and Tumor-Suppressive Properties in a Transgenic Model Mol. Cell. Biol., September 1, 1999; 19(9): 6408 - 6414. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, L. Dong, B. Saville, and S. Safe Transcriptional Activation of E2F1 Gene Expression by 17{beta}-Estradiol in MCF-7 Cells Is Regulated by NF-Y-Sp1/Estrogen Receptor Interactions Mol. Endocrinol., August 1, 1999; 13(8): 1373 - 1387. [Abstract] [Full Text] |
||||
![]() |
H. L. Yang, Y. B. Dong, M. J. Elliott, T. J. Liu, C. Atienza Jr., A. Stilwell, and K. M. McMasters Adenovirus-mediated E2F-1 Gene Transfer Inhibits MDM2 Expression and Efficiently Induces Apoptosis in MDM2-overexpressing Tumor Cells Clin. Cancer Res., August 1, 1999; 5(8): 2242 - 2250. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamamoto, J.-W. Soh, T. Monden, M. G. Klein, L. M. Zhang, H. Shirin, N. Arber, N. Tomita, I. Schieren, C. A. Stein, et al. Paradoxical Increase in Retinoblastoma Protein in Colorectal Carcinomas May Protect Cells from Apoptosis Clin. Cancer Res., July 1, 1999; 5(7): 1805 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blattner, A. Sparks, and D. Lane Transcription Factor E2F-1 Is Upregulated in Response to DNA Damage in a Manner Analogous to That of p53 Mol. Cell. Biol., May 1, 1999; 19(5): 3704 - 3713. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Evan and T. Littlewood A Matter of Life and Cell Death Science, August 28, 1998; 281(5381): 1317 - 1322. [Abstract] [Full Text] |
||||
![]() |
M.-H. Jeng, C. Kao, L. Sivaraman, S. Krnacik, L. W. K. Chung, D. Medina, O. M. Conneely, and B. W. O'Malley Reconstitution of Estrogen-Dependent Transcriptional Activation of an Adenoviral Target Gene in Select Regions of the Rat Mammary Gland Endocrinology, June 1, 1998; 139(6): 2916 - 2925. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. U. Ha, D. L. Segev, D. Barbie, P. T. Masiakos, T. T. Tran, D. Dombkowski, M. Glander, T. R. Clarke, H. K. Lorenzo, P. K. Donahoe, et al. Mullerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism J. Biol. Chem., November 17, 2000; 275(47): 37101 - 37109. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |